SMALL MOLECULE OUTSOURCING
Improve The Performance Of Your Small And Large Molecule Medicines
Explore the latest in nanotechnology advancements including recent clinical data, formulation applications, and API optimization to NanoImprove formulations.
CESS Technology
Learn how the award-winning CESS® technology can be used in Nanoforming™ future medicines to increase bioavailability for molecules with poor solubility.
Integrating Early Development With Clinical Supply
In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes.
Developing Long-Acting Contraceptive Injectables
Adare Pharma Solutions is crafting contraceptive injections that can last up to a year, increasing accessibility and allowing women to choose protection on their own terms.
Continuous Flow Techniques For Fine Chemical Manufacturing
Explore the advantages and challenges of continuous flow processes and the concept of mini-monoplant technology, along with examples that demonstrate the versatility of continuous processing.
Understanding FDA Calibration Requirements And Best Practices For Reducing Risks
Become equipped with the tools and strategies needed to strengthen your calibration efforts and better position your organization for success in regulatory audits.
How To Design An HPAPI Plant And Its Containment Systems
Dr. Friederike Hermann, head of occupational hygiene and biosafety, shares her expertise on requirements and evaluating the right containment that meets the needs of all process steps and stakeholders.
Challenges Of Moving A Bioconjugate Candidate From Clinic To Market
Drug developers must successfully navigate the path to market, under the growing pressure of regulation and competition, and while carefully managing technical and financial risk.
ADHD Awareness: How This Novel Technology Can Guide The Way
Explore Nanoform's innovative nanoparticle technology and the value it can bring to molecules in development or products on the market for neurological disorders such as ADHD.
Cambrex Scientist Spotlight: Shawn Conway
Shawn Conway, Senior Director of Operations in High Point, NC, leads a dynamic team of engineers and chemists at Cambrex, focused on supporting clients throughout the entire product life cycle.
From Powder To Particles With Jet Milling
Gain valuable insights into the jet milling process and Quality by Design approach for inhalation drug delivery and their potential applications in drug development.
Discovering A Unique Multimillion Euro Nanotechnology Facility
Dr. David Rowe, Head of Manufacturing at Nanoform, provides an overview of Nanoform's manufacturing capabilities and introduces a new, state-of-the-art nanotechnology facility.
Integration From Formulation Development To Manufacturing, Packaging
Adare Pharma Solutions' Pessano, Italy facility offers 220,000 sq. ft. of end-to-end services, including R&D, formulation development, clinical and commercial manufacturing, packaging, and advanced analytical capabilities.
The Fusion-Based, Solvent-Free Process Disrupting Spray Drying
Review a commercially-ready process capable of reproducing spray-dried dispersions with less manufacturing complexity and environmental impact, and out-designing and outperforming spray drying.
Collaboration With Clients
If you're looking for a dedicated partner who prioritizes trust, transparent communication, and delivering results that exceed expectations, let's work together to drive your project's success and create lasting impact.
Formulating Better ASDs And mAbs: Advances In Applied Nanotechnology
Learn about new data on nanotechnology formulations for multiple dose forms and routes of delivery, including oral, long-acting injectables, inhalation, and ophthalmic.
How To Safely Handle Your Antibody Drug Conjugate
Internal specialized occupational toxicology and industrial hygiene knowledge can help solve the mystery of safe handling ADCs.
How To Deal With The Complexity Of Drugs In Clinical Development
Discover how to advance new compounds with complex chemistry through each stage of development by refining processes to give fit-for-purpose manufacturability and yields.
Scaling Up A Revolutionary Amorphous Solid Dispersion Platform
Process parameter and quality attribute relationships, including those for typical pre- and post-ASD unit operations, will be explored in the context of real-world examples.
Local Delivery For Treatment Of Lung Cancer
Explore two case studies where lung cancer therapies were delivered to the lung by dry powder inhaler in a rat model and evaluated for efficacy, confirming local delivery is a promising route to treat lung cancer.
Environmental Sustainability: Wastewater Incineration Reduction
Discover an approach to wastewater treatment that reduces the environmental impact of small molecules production and introduces advanced treatment methodologies to avoid wastewater incineration.
Solvent-Free, Fusion-Based Amorphic Dispersion Process
Discover a solvent-free, fusion-based process that leverages frictional and shear forces to rapidly convert crystalline drugs and polymers into amorphous solid dispersions (ASDs).
Improving Bioavailability, Drug Loads, And Pill Burdens Of Solid Dispersions
Explore the pros and cons of marketed amorphous solid dispersions with so-far unpublished data as well as a green alternative to ASDs: best-in-class nanotechnology to manufacture nanocrystals.
Fostering A Collaborative, Cross-Functional Approach
Our collaborative environment ensures efficient project execution and thorough product testing across multiple sites, consistently delivering client satisfaction.
The Future Of Oral Solid Dose Development And Innovation
Tom Sellig, CEO of Adare, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.
Taste Masking 101: Applications And Technologies
Learn about key product parameters affecting patient acceptability and therapy adherence and taste masking strategies, including organoleptic and barrier coating approaches and microencapsulation technologies.
Patient- And Planet-Centric Bioavailability And Sustained Delivery
By reducing the size of drug particles, nanoforming offers new opportunities — from increased bioavailability to sustained drug delivery. Discover the potential benefits supported by case studies.
Cambrex Scientist Spotlight: Ross McLellan
Ross McLellan, Team Lead for Solid Form Screening in Edinburgh, UK, leads a team dedicated to complex solid form screening and materials characterization for Cambrex’s global client base.
Cambrex Scientist Spotlight: Jonas Nilsson
Jonas Nilsson, Principal Scientist based in Karlskoga, Sweden, leads a team of synthetic chemists focused on process development and optimization.
Cambrex Scientist Spotlight: Luigi Bellone
Luigi Bellone, Head of Quality Assurance in Paullo, Milan, brings over 20 years of experience in quality assurance (QA), quality control (QC), and regulatory compliance within the pharmaceutical industry.
Considerations For Complex Formulations: How To Simplify Your Outsourcing
Experts share the necessary development and manufacturing considerations for a smooth tech transfer, exploring these challenges in depth, and discuss the questions you should be asking your manufacturer.
How Can Nanoparticle Engineering Make The Difference For Alzheimer's?
Commercial Insights Officer Jamie Unwin discusses the power of innovative nanoparticle engineering technology and AI-based digital twin.
Rapid Developability Assessment Of Early Phase Molecules
A case study illustrating how to use PBPK modeling, the developability classification system, and the biopharmaceutics drug distribution classification system to facilitate development of a molecule.
Cambrex Scientist Spotlight: Kelly McGuill
McGuill is dedicated to inspiring the next generation of scientists. Her commitment to quality ensures that clients stay compliant and focused on advancing to the next phase of their projects.
Cambrex Scientist Spotlight: Elena Bejan
Holding a Ph.D. in organic chemistry from Paris-Sud University and an MBA from the Rotman School of Management, Bejan leads R&D efforts at Cambrex with a focus on scientific innovation.
Cambrex Scientist Spotlight: Daniel Kirschner
With a Ph.D. in bioanalytical chemistry from the University of Alaska Fairbanks, Kirschner brings nearly 15 years of experience in pharmaceutical development across biotech and CDMO sectors.